The development and maturation of oocytes in fish have been studied extensively [1, 2] . The complex and coordinated actions of pituitary gonadotropins, ovarian-derived growth factors, and sex steroids occur in concert to ensure the ovulation and spawning of hundreds of viable oocytes from fish ovaries. It is well established that steroid hormones, notably estrogens and progestins, are involved with oocyte growth and resumption of meiosis, respectively. The ovarian follicle produces large amounts of 17b-estradiol (E2) to support the synthesis of vitellogenin by the liver; this protein is sequestered by the growing oocytes. During this period of growth, the oocytes are arrested at the first meiotic prophase by high intracellular levels of cAMP. Intraoocyte levels of cAMP decline when gonadotropin (luteinizing hormone) levels surge during the periovulatory period, leading to the increased synthesis of a maturation-inducing steroid (MIS; e.g., 17a,20b-dihydroxy-4-pregnen-3-one and related progestins) that induces final maturation of the oocyte via nongenomic actions involving a membrane progesterone receptor [3] .
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The number of studies investigating the factors and biochemical pathways involved in the inhibition of the resumption of meiosis in fish has increased during recent years. The Thomas research group has contributed substantially to our understanding of the inhibitory role that E2 plays in controlling the onset of oocyte maturation, including the receptor through which it acts and the signal transduction pathways that are responsive downstream of receptor activation [4] [5] [6] [7] . The following sections highlight these advancements and specifically address the recent contributions made in the manuscript by Peyton and Thomas published in this issue of Biology of Reproduction [7] .
Estrogenic Inhibition of the Resumption of Meiosis
Several basic experiments conducted by the Thomas group using two model teleosts, Atlantic croaker (Micropogonias undulatus) and zebrafish (Danio rerio), have demonstrated that oocytes cultured in vitro with an aromatase inhibitor exhibit an increased level of spontaneous maturation that is reversible by the addition of exogenous E2. As well, MIS-induced maturation of the oocytes is attenuated by the addition of E2 to the culture media [4, 5] . Oocytes denuded of their follicle layers, either through manual or enzymatic means (thereby removing their endogenous source of estrogens), also show increased rates of maturation. The Thomas research group has shown consistent results with the use of the oocyte maturation bioassay that is based on visualizing germinal vesicle breakdown (GVBD). They have shown that Esr1 (ERa) and Esr2 (ERb) are not involved in mediating the inhibitory effects of estrogens on oocyte maturation. Taken together, their results are consistent with an inhibitory role of estrogens in the control of meiotic cell-cycle progression in these fish, which Pang et al. [4] propose as a mechanism for preventing the precocious maturation of the oocytes.
Several lines of evidence now suggest that the estrogen inhibition of fish oocyte maturation is mediated through a seven-transmembrane receptor, G protein-coupled estrogen receptor (Gper; also known as GPR30) [4] [5] [6] [7] . This discovery comes on the heels of very recent mammalian research that implicates GPER in the development or progression of cancers (i.e., breast, ovarian, endometrial, and thyroid) and the regulation of a broad suite of physiological functions (for review, see [8] ). Research conducted by Peyton and Thomas [7] has provided additional evidence that the inhibitory actions of estrogens on oocyte maturation are mediated though Gper, which previously was localized to and found to be highly expressed on the surface of the oocyte [4] . Peyton and Thomas [7] confirmed that denuded zebrafish oocytes that are devoid of a source of estrogens exhibit a high degree of spontaneous maturation. The addition of E2-bovine serum albumin (a membrane-impermeant estrogen) blocked the spontaneous maturation of the denuded oocytes. Further studies showed that GPER-specific agonist (G-1) attenuated spontaneous oocyte maturation and that a GPER-specific antagonist (G-15) blocked the inhibitory actions of E2 on oocyte maturation.
The notion that a physiological function of Gper is as a membrane estrogen receptor that mediates nongenomic actions of E2 in tissues is not without its detractors, and scientific arguments for and against its function have been discussed recently [8] [9] [10] . However, the Thomas research group has conducted solid scientific work that shows very similar binding characteristics and the activation of the same estrogen-signaling pathways by the Gper of a teleost fish (Atlantic croaker) and GPER of humans. The conservation of estrogen signaling through GPER in two distantly related vertebrate groups (mammals and fish) lends great support to the idea that a 
and zebrafish will spur further investigation into the Gper of other teleosts, especially given the diverse reproductive strategies and gonadal development of fish. No doubt the potential role that Gper plays in mediating the effects of endocrine-disrupting compounds in fish will continue as a result of the early studies by the Thomas group [11] .
Gper Signaling and Oocyte Maturation
Atlantic croaker Gper, similar to human GPER, is coupled to a stimulatory G protein (Gs) that causes increased adenylyl cyclase activity and elevated cAMP levels, which are involved in maintaining estrogen-induced meiotic arrest of Atlantic croaker oocytes [4] . Peyton and Thomas [7] continued this line of research using zebrafish to investigate the potential involvement of other second messengers downstream of E2 activation of Gper. Through a series of in vitro experiments using the zebrafish GVBD bioassay and numerous pharmacological compounds, their results suggest that estrogens act through Gper to transactivate the epidermal growth factor receptor (Egfr), causing an increase in mitogen-activated protein kinase (Mapk) 3/1 phosphorylation. Based on their results, they aptly conclude that the maintenance of meiotic arrest in zebrafish oocytes is at least partially regulated through the activation of Src family kinases, matrix metalloproteinase (Mmp), Egfr (ErbB1), and Mapk3/1 via estrogen-induced Gper signaling [7] .
Specifically, Peyton and Thomas [7] showed that the inhibitory effect of a GPER agonist on oocyte maturation was blocked by the addition of an SRC inhibitor or an MMP inhibitor, whereas an MMP activator decreased the proportion of oocytes undergoing spontaneous maturation. These studies support the contention that activators leading to the generation of epidermal growth factor (Egf) contribute to the estrogeninduced inhibition of oocyte maturation. RT-PCR and Western blot analysis confirmed the presence of Egf and Egfr proteins in denuded zebrafish oocytes. Additional experiments examined the actions of EGFR inhibitors and showed that transactivation of Egfr, but not Erbb2, was required to maintain the meiotic arrest of oocyte. Interestingly, the addition of inhibitors of ERBB2 attenuated the stimulatory effects of MIS on the maturation of denuded oocytes, suggesting that both receptor types may play a role in aspects of the maturation process. Finally, other studies have provided evidence for Mapk signaling downstream of Egfr activation. Mitogenactivated protein kinase kinase 1/2 inhibitors reversed the inhibitory effects of estrogens on oocyte maturation. These investigations have demonstrated that estrogens and Egf led to the phosphorylation of Mapk3/1 as part of the downstream actions of Gper signaling and that this phosphorylation was blocked by an EGFR inhibitor. Collectively, these studies support the concept that the Egf/Mapk-signaling pathway participates in the estrogen-mediated inhibition of oocyte maturation in the zebrafish.
Peyton and Thomas [7] have presented the first report, to our knowledge, of the involvement of Egfr signaling in the maintenance of meiotic arrest in a vertebrate and, seemingly, the first paper to describe the involvement of Egfr signaling in denuded oocytes. Aspects of the experiments described in the Peyton and Thomas article [7] are consistent with previous studies that found estrogens activate membrane-associated MMPs, resulting in release of EGF ligands and transactivation of the EGFR, leading to activation of MAPK through GPER in breast cancer cells [12] [13] [14] . However, their suggestion [7] that an estrogen-induced, Egf-mediated pathway is involved in the regulation of meiotic arrest in denuded zebrafish oocytes will require further confirmation. This is because earlier studies have established that intact zebrafish ovarian follicles express Egf and Egfr [15] and that recombinant human EGF promotes oocyte maturation through a pathway mediated by increases in the expression of activin [16] . EGF is also well known for its potent stimulatory effect on the oocyte maturation in other mammalian species [17, 18] .
Summary
The work of Peyton and Thomas in this issue [7] contributes valuable insight regarding the complex interactions of Gper and Egf in maintaining the meiotic arrest in zebrafish ovarian follicles. In addition, these studies highlight a number of areas of significant uncertainty that need to be addressed to better understand the hormonal control of oocyte maturation. The opposing effect of Egf treatment of intact versus denuded oocytes raises questions about the sites of synthesis and locations of hormone receptors and how these may be compartmentalized in the follicle cells and the oocyte. Some uncertainty also exists as to the precise nature of the Egf FIG. 1. Summary of hormones and growth factors known to stimulate or inhibit oocyte maturation in the zebrafish (Danio rerio). The illustration shows changes in translucence of the oocyte as it undergoes GVBD in the zebrafish oocyte maturation bioassay. For additional information on the hormonal regulators of oocyte maturation, see [2, 7, 16, [25] [26] [27] [28] .
EGF AND GPER REGULATION OF OOCYTE MATURATION 7 ligands and receptors in the zebrafish. Peyton and Thomas observed very different effects when ligands presumed to be specific to different classes of mammalian EGFRs were tested in the zebrafish. This begs the question not only about the characteristics of the endogenous Egf ligand in the zebrafish but also whether other EGF-like molecules exist in the zebrafish, as has been found in other organisms [19, 20] . Importantly, in mammals, various EGF-like peptides (e.g., amphiregulin, betacellulin, and epiregulin), as opposed to EGF, have been implicated in the control of oocyte maturation [21] [22] [23] . Recently, Egf, transforming growth factor alpha, betacellulin, and heparin-binding EGF-like growth factor were identified in zebrafish ovarian follicles [24] , although their roles in oocyte maturation are unknown. Clearly, many of the complex networks that regulate oocyte maturation in fish, birds, and mammals were in place early in vertebrate evolution (Fig. 1) . The comparable results (e.g., binding characteristics of Gper and common signal transduction pathways) obtained by the Thomas group in humans and fish emphasize that fish oocyte bioassays may have broad application for studies of the regulation of oocyte maturation in vertebrates.
